Hill Labs Competitors

Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories. Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients. The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals. More information is available at www.questdiagnostics.com. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery. Language Assistance / Non-Discrimination Notice Asistencia de Idiomas / Aviso de no Discriminación 語言協助 / 不歧視通知 www.QuestDiagnostics.com/home/nondiscrimination

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 59 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

We provide health and disability services to more than half a million people living in central Auckland, regional services for Northland and greater Auckland, and specialist national services for the whole of New Zealand. Our main sites are Auckland City Hospital and Starship Child Health, located in central Auckland. We serve a population of almost half a million people across central Auckland, as well as providing some services for the Northern region (such as adult cancer treatment) and services for the whole of New Zealand (including organ transplants). Our services are not just limited to the hospital setting, but include the provision or funding of many services within our community that support the overall health of our population – these include community mental health services, community lab tests and dental health. Te Toka Tumai Auckland (formally Auckland DHB) provides services at two main hospital sites – Auckland City Hospital and Greenlane Clinical Centre. Auckland DHB is home to New Zealand’s largest clinical research facility and it is the largest trainer of doctors in the country. Interested in joining our team of 10,000+ and helping us improve the health of Aucklanders? Check out our current vacancies at: http://careers.adhb.govt.nz/. Rules for commenting on our page: Be polite and respectful. Don’t post defamatory, vulgar, obscene or threatening material. Do not post comments which breach the confidentiality of our patients, their relatives, staff or other individuals. Any content that does not abide by the rules of engagement will be removed.